Description

▪ Introduction

Boldenox 250 mg by Novotex Pharma contains Boldenone Undecylenate, a long-acting injectable compound primarily studied for its medical applications in veterinary medicine, particularly to improve weight gain, appetite, and general physical condition in animals. In laboratory research, it is investigated for its anabolic effects, including potential benefits on muscle mass retention, red blood cell production, and overall metabolic efficiency.

Manufactured under stringent pharmaceutical-grade standards, each pack of 10 × 1 mL ampoules ensures consistent purity, concentration, and sterility — intended strictly for laboratory and analytical use.

▪ Product Details (Bulleted)

• Active Ingredient: Boldenone Undecylenate

• Concentration: 250 mg/mL

• Form: Injectable solution (intramuscular)

• Package Size: 10 ampoules × 1 mL each

• Intended Use: Laboratory and analytical use

▪ Pharmacokinetics

Boldenone Undecylenate exhibits a long half-life, with research protocols typically dosing once every 2–3 weeks to maintain stable plasma concentrations. Its sustained release supports prolonged anabolic activity with reduced dosing frequency.

▪ Usage Recommendations

• Typical Research Dosage (historic/experimental): 200–400 mg every 2–3 weeks, per study design

• Current Use: Intended exclusively for laboratory and research applications

• Administration Route: Intramuscular injection with aseptic technique

• Use Statement: Strictly for laboratory and analytical use only

▪ Disclaimer

This product is strictly intended for laboratory research use only. It is not approved for human consumption or therapeutic applications. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with pre-existing medical conditions. Research must comply with all applicable regulations, institutional protocols, and ethical standards.